In a recent article titled “ Big Pharma says ‘Thanks, but No Thanks’ to their own HEOR groups, ” Professor Scott Ramsey from ...

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI ponders the next big developments and breakthroughs he expects to see in the ...

Statistically significant means there is a very high likelihood the drug impacted its target. But if data are not clinically ...

The energy component—and cost—associated with artificial intelligence should not be overlooked in all the excitement.

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1 ...

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

Monica Martin de Bustamante, senior partner and head of advisory at Trinity Life Sciences, spoke with Pharmaceutical ...

Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient ...

In this Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, speaks about how distrust and uncertainty ...

New cases are still being recorded, and the impact of long COVID has yet to be fully determined. Invivyd announced a ...